T1	Participants 13 60	polyarteritis nodosa and Churg-Strauss syndrome
T2	Participants 268 280	236 patients
T3	Participants 139 198	polyarteritis nodosa (PAN) and Churg-Strauss syndrome (CSS)
T4	Participants 576 599	71 patients (1981-1983)
T5	Participants 925 953	patients without HBV markers
T6	Participants 972 997	patients with HBV markers
T7	Participants 1002 1033	78 patients without HBV markers
T8	Participants 1124 1159	33 patients with PAN related to HBV
